Contact
Please use this form to send email to PR contact of this press release:
Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281
TO:
Please use this form to send email to PR contact of this press release:
Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281
TO: